Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 2Astrocytoma 2Xerostomia 1Oligodendroglioma 1Neuroblastoma 1Head and Neck Neoplasms 1Glioma 1Brain Neoplasms 1Adenoviridae Infections 1

Interventions

atezolizumab 2Gemcitabine 2Cell Count 2ziprasidone 1valrubicin 1tretazicar 1pembrolizumab 1liposomal doxorubicin 1fludarabine phosphate 1fludarabine 1enadenotucirev 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Vaccines 1Tumor Necrosis Factor-alpha 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Sevelamer 1Rocuronium 1Radiotherapy 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Oncolytic Virotherapy 1Nifedipine 1Nafcillin 1Molindone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoviridae Infections × Genetic Engineering × Clear all
NCT00372320 2018-09-11

Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
17 enrolled
Head & Neck

Adenoviridae Infections, Head and Neck Neoplasms, Xerostomia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡